EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reverse Cascade Genetic Screening for Revealing New Cases of Familial Hypercholesterolemia in Russia: Pilot Project

Valentina V Miroshnikova, Artem D Izyumchenko, Nataliia N Smirnova, Natalia B Kuprienko, Soreiia A Urazgildeeva, Maria N Grunina, Svetlana V Linkova, Kseniia V Dracheva, Kseniia O Tanayants, Alina A Petrik, Oleg S Glotov, Kristina V Legostaeva und 5 weitere

Frontiers in Bioscience-Scholar · 2026

DOI: 10.31083/fbs47474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Scholar, 2026. Verfasst von Valentina V Miroshnikova und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Radiation Biophysics, Petersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre «Kurcha…. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Genetic Testing. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation under the strategic academic leadership program 'Priority 2030'', Ministry of Science and Higher Education of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation under the strategic academic leadership program ‘Priority 2030′’.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reverse cascade genetic screening, following initial lipid testing, is an effective strategy for the early diagnosis of familial hypercholesterolemia (FH) and related hereditary dyslipidemias. In this study, we present the results of a pilot project in Russia.

Methods

This was a hybrid retrospective–prospective cross-sectional study. Analysis of 1897 lipid screenings of children referred to the main pediatric centers in St. Petersburg, Russia, demonstrated that 60 (3.2%) met the Simon Broome criteria for FH, defined as total cholesterol (TC) ≥6.5 mmol/L or low-density lipoprotein cholesterol (LDL-C) ≥4 mmol/L. All families were invited to undergo genetic testing, regardless of their history, with 35 (58%) families participating in the second stage of the study. Targeted sequencing was performed for children, and Sanger sequencing was performed for variant validation in children and their family members.

Results

Sixteen children were shown to have causal variants in dyslipidemia-associated genes, including fourteen (40% of 35 tested children) with hereditary dyslipidemias: twelve FH cases (linked to LDLR and APOB genetic variants), one dysbetalipoproteinemia case (APOE), and one sitosterolemia case (ABCG8). Two children were heterozygous for sitosterolemia variants (one case with ABCG5, one case with ABCG8). Family history of FH or atherosclerotic cardiovascular disease (ASCVD) was reported in only 50% of cases, regardless of whether a causal variant was present. TC and LDL-C were higher in the causal variant-positive subgroup. Receiver operating characteristic curve analysis revealed that LDL-C >4.8 mmol/L acted as a diagnostic indicator of disease causing variant with 84% accuracy, 93% sensitivity, and 73% specificity.

Conclusions

Reverse cascade genetic screening following selective lipid testing in children is an effective strategy to reveal new FH and other hereditary dyslipidemia cases, helping to mitigate future ASCVD risks and early mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIGenetic TestingHumansPilot ProjectsFemaleMaleRussiaChildCross-Sectional StudiesChild, PreschoolRetrospective StudiesCholesterol, LDLProspective StudiesAdolescentReceptors, LDL

Stichwörter der Autor:innen

dyslipidemiasfamilial hypercholesterolemiahigh-throughput nucleotide sequencinghyperlipoproteinemia type IIreverse cascade screening

Substanzen

Cholesterol, LDLReceptors, LDL

Autor:innen und Institutionen

  • Department of Molecular and Radiation Biophysics, Petersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre «Kurchatov Institute», 188300 Gatchina, Russia.
  • Department of Molecular Genetic and Nanobiological Technologies, Pavlov First Saint Petersburg State Medical University, 197022 Saint-Petersburg, Russia.
  • Department of Pediatrics, Pavlov First Saint Petersburg State Medical University, 197022 Saint-Petersburg, Russia.
  • Center for Atherosclerosis and Lipid Metabolism Disorders of L. G. Sokolov Northwest District Scientific and Clinical Center, 194291 Saint Petersburg, Russia.
  • Saint-Petersburg Medical and Social Institute, 195271 Saint-Petersburg, Russia.
  • Children Municipal Multi-Specialty Clinical Center of High Medical Technology Named after K.A. Rauhfus, 191036 Saint-Petersburg, Russia.

Förderung

  • Ministry of Science and Higher Education of the Russian Federation under the strategic academic leadership program 'Priority 2030''
  • Ministry of Science and Higher Education of the Russian Federation
  • Ministry of Science and Higher Education of the Russian Federation under the strategic academic leadership program ‘Priority 2030′’

Zitieren

APA

Miroshnikova, V. V., Izyumchenko, A. D., Smirnova, N. N., Kuprienko, N. B., Urazgildeeva, S. A., Grunina, M. N., Linkova, S. V., Dracheva, K. V., Tanayants, K. O., Petrik, A. A., Glotov, O. S., Legostaeva, K. V., Kulikov, A. N., Ilyinets, I. V., Ivashikina, T. M., Klochko, L. A., & Pchelina, S. N. (2026). Reverse Cascade Genetic Screening for Revealing New Cases of Familial Hypercholesterolemia in Russia: Pilot Project. Frontiers in Bioscience-Scholar. https://doi.org/10.31083/fbs47474

Vancouver

Miroshnikova VV, Izyumchenko AD, Smirnova NN, Kuprienko NB, Urazgildeeva SA, Grunina MN, et al. Reverse Cascade Genetic Screening for Revealing New Cases of Familial Hypercholesterolemia in Russia: Pilot Project. Frontiers in Bioscience-Scholar. 2026. doi:10.31083/fbs47474

BibTeX
@article{Miroshnikova2026,
  author = {Miroshnikova, Valentina V and Izyumchenko, Artem D and Smirnova, Nataliia N and Kuprienko, Natalia B and Urazgildeeva, Soreiia A and Grunina, Maria N and Linkova, Svetlana V and Dracheva, Kseniia V and Tanayants, Kseniia O and Petrik, Alina A and Glotov, Oleg S and Legostaeva, Kristina V and Kulikov, Alexandr N and Ilyinets, Irina V and Ivashikina, Tat'yana M and Klochko, Lidiya A and Pchelina, Sofya N},
  title = {Reverse Cascade Genetic Screening for Revealing New Cases of Familial Hypercholesterolemia in Russia: Pilot Project},
  journal = {Frontiers in Bioscience-Scholar},
  year = {2026},
  doi = {10.31083/fbs47474}
}
Kostenlos starten →